HUP0202671A3 - Optically active isomers of ketotifen and therapeutically active metabolites thereof - Google Patents

Optically active isomers of ketotifen and therapeutically active metabolites thereof

Info

Publication number: HUP0202671A3
Authority: HU; Hungary
Prior art keywords: ketotifen; isomers; metabolites; optically active; therapeutically
Prior art date: 1999-09-13

Application number

HU0202671A

Other languages

English (en)

Original Assignee

Bridge Pharma Inc Sarasota

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-13

Filing date

2000-09-12

Publication date

2005-01-28

2000-09-12 Application filed by Bridge Pharma Inc Sarasota filed Critical Bridge Pharma Inc Sarasota

2002-11-28 Publication of HUP0202671A2 publication Critical patent/HUP0202671A2/hu

2005-01-28 Publication of HUP0202671A3 publication Critical patent/HUP0202671A3/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Nutrition Science (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

HU0202671A 1999-09-13 2000-09-12 Optically active isomers of ketotifen and therapeutically active metabolites thereof HUP0202671A3 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date
US15356699P	1999-09-13	1999-09-13
US19798500P	2000-04-15	2000-04-15
US19790500P	2000-04-15	2000-04-15
US19790600P	2000-04-15	2000-04-15
US19736300P	2000-04-15	2000-04-15

Publications (2)

Publication Number	Publication Date
HUP0202671A2 HUP0202671A2 (hu)	2002-11-28
HUP0202671A3 true HUP0202671A3 (en)	2005-01-28

Family

ID=27538454

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0202671A HUP0202671A3 (en)	1999-09-13	2000-09-12	Optically active isomers of ketotifen and therapeutically active metabolites thereof

Country Status (18)

Country	Link
US (3)	US7226934B1 (hu)
EP (1)	EP1218007B1 (hu)
JP (1)	JP5116928B2 (hu)
CN (1)	CN1391475A (hu)
AR (1)	AR034396A1 (hu)
AT (1)	ATE516804T1 (hu)
AU (1)	AU782816B2 (hu)
BR (1)	BR0013935A (hu)
CA (1)	CA2383222C (hu)
CY (1)	CY1112605T1 (hu)
DK (1)	DK1218007T3 (hu)
HU (1)	HUP0202671A3 (hu)
IL (2)	IL148368A0 (hu)
MX (1)	MXPA02002658A (hu)
MY (1)	MY134888A (hu)
PL (1)	PL353586A1 (hu)
PT (1)	PT1218007E (hu)
WO (1)	WO2001019367A1 (hu)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE516804T1 (de) *	1999-09-13	2011-08-15	Bridge Pharma Inc	Optisch aktive isomere von ketotifen und deren therapeutisch wirksame metabolite
WO2008153761A1 (en) *	2007-05-23	2008-12-18	Mastcell Pharmaceuticals, Inc.	Methods
WO2009142772A2 (en)	2008-05-23	2009-11-26	Mastcell Pharmaceuticals, Inc.	Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
KR101359102B1 (ko) *	2008-06-13	2014-02-05	케이스 웨스턴 리저브 유니버시티	각막 염증을 치료하는 조성물 및 방법
US8741930B2 (en) *	2008-10-24	2014-06-03	Bridge Pharma, Inc.	Treating xerophthalmia with norketotifen
US8765787B2 (en) *	2008-11-21	2014-07-01	Bridge Pharma, Inc.	Methods of treatment of xerophthalmia with self-preserving ocular formulations of norketotifen
EP2408302A4 (en) *	2009-03-17	2012-08-15	Aciex Therapeutics Inc	OPHTALMIC FORMULATIONS OF KTOTICENE AND METHODS OF USE
CN103619839B (zh) *	2011-06-28	2016-06-01	福建省闽东力捷迅药业有限公司	抗-变态反应的苯并环庚并噻吩衍生物
US8557846B1 (en)	2012-10-23	2013-10-15	Bridge Pharma, Inc.	Medicinal treatment of dermal diseases in dogs
US8778971B2 (en) *	2012-10-23	2014-07-15	Bridge Pharma, Inc.	Medicinal treatment of dermal diseases in companion animals
US20150272941A1 (en) *	2012-10-30	2015-10-01	Bridge Pharma, Inc.	Medicinal treatment of chronic pulmonary inflammatory diseases with norketotifen
US20140120121A1 (en) *	2012-10-30	2014-05-01	Bridge Pharma, Inc.	Medicinal treatment of atopic inflammatory diseases
US9138431B2 (en)	2013-08-06	2015-09-22	Bridge Pharma, Inc.	Methods of treatment of histamine H-4 receptor-related pruritus
US9345697B2 (en) *	2013-08-06	2016-05-24	Bridge Pharma, Inc.	Methods of treatment of non-histaminic pruritus
US9439895B2 (en) *	2013-08-06	2016-09-13	Bridge Pharma, Inc.	Methods of treating pruritic conditions mediated through non-histaminergic mechanisms in diabetic patients
CN104059056B (zh) *	2014-06-26	2017-08-25	福建省闽东力捷迅药业有限公司	一种富马酸卢帕替芬晶型b及其制备方法
DK3307270T3 (en) *	2015-06-11	2019-01-07	Bridge Pharma Inc	PROCEDURES FOR TREATING NON-HISTAMINE RELATED MAMMAL PRURITUS
US9694003B2 (en)	2015-10-15	2017-07-04	Bridge Pharma, Inc.	Formulations and methods for treating high intraocular pressure
CN106243096B (zh) *	2016-07-29	2019-11-29	上海璃道医药科技有限公司	三环类药物的新用途
MX389999B (es) *	2016-09-08	2025-03-11	Emergo Therapeutics Inc	Estabilizadores de mastocitos para el tratamiento de hipercitoquinemia e infeccion viral
WO2018075574A1 (en)	2016-10-18	2018-04-26	Emergo Therapeutics, Inc.	Mast cell stabilizers for treatment of chronic inflammatory conditions
US10959992B2 (en)	2019-02-22	2021-03-30	Bridge Pharma Inc.	Methods of treatment of asthma and COPD
US20200268734A1 (en) *	2019-02-22	2020-08-27	Bridge Pharma, Inc.	Methods of treatment of respiratory disorders

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1089483A (en)	1964-02-04	1967-11-01	Sandoz Ltd	Improvements in or relating to 4h-benzo(4,5)cyclohepta (1,2-b) thiophene derivatives
FR1447527A (fr)	1964-08-11	1966-07-29	Sandoz Sa	Nouveaux benzo-cyclohepta-thiophènes et leur préparation
CH531000A (de)	1970-03-11	1972-11-30	Sandoz Ag	Verfahren zur Herstellung neuer Benzocycloheptathiophene
BE794377A (fr) *	1972-01-24	1973-07-23	Sandoz Sa	Nouveaux derives du benzo-cyclohepta-thiophene
US3994974A (en) *	1972-02-05	1976-11-30	Yamanouchi Pharmaceutical Co., Ltd.	α-Aminomethylbenzyl alcohol derivatives
US4073915A (en)	1975-05-20	1978-02-14	Sandoz Ltd.	Treating asthma
US4128549A (en)	1976-02-27	1978-12-05	Sandoz Ltd.	Precursors of 4-(1-alkyl-4-piperidylidene-4H-benzo[4,5]cyclohepta-[1,2-b]thiophen-10(9H)-ones
CS263993B1 (cs)	1988-03-11	1989-05-12	Polivka Zdenek	Způsob přípravy čistých enantiomerů 4- (l-meíhyl-4-piperidyliden) -4,9-dihydrobenzo [ 4,5) cyklohepta [ 1,2-b ] - thiofen-lQ-onu
CA1341370C (en)	1988-04-28	2002-06-18	John J. Powinski	Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents
GB9012926D0 (en) *	1990-06-09	1990-08-01	Scras	Pyrrolo-pyridine derivatives
WO1992006970A1 (en) *	1990-10-10	1992-04-30	Schering Corporation	Bis-benzo cyclohepta piperidylidene, piperidine and piperazine compounds, compositions and methods of use
EP0616524B1 (en) *	1991-12-12	1998-10-07	Glaxo Group Limited	Medicaments
PT613371E (pt) *	1991-12-18	2002-07-31	Astrazeneca Ab	Nova combinacao de formoterol e budesonido
US6040344A (en) *	1996-11-11	2000-03-21	Sepracor Inc.	Formoterol process
ATE319450T1 (de)	1997-04-03	2006-03-15	Bridge Pharma Inc	Benzocycloheptha-thiophen verbindungen
AU7833698A (en) *	1997-06-09	1998-12-30	Bridge Pharma, Inc.	Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
ATE516804T1 (de) *	1999-09-13	2011-08-15	Bridge Pharma Inc	Optisch aktive isomere von ketotifen und deren therapeutisch wirksame metabolite

2000
- 2000-09-12 AT AT00966709T patent/ATE516804T1/de active
- 2000-09-12 EP EP00966709A patent/EP1218007B1/en not_active Expired - Lifetime
- 2000-09-12 AU AU77014/00A patent/AU782816B2/en not_active Ceased
- 2000-09-12 DK DK00966709.8T patent/DK1218007T3/da active
- 2000-09-12 WO PCT/US2000/024892 patent/WO2001019367A1/en not_active Ceased
- 2000-09-12 PT PT00966709T patent/PT1218007E/pt unknown
- 2000-09-12 BR BR0013935-1A patent/BR0013935A/pt not_active Application Discontinuation
- 2000-09-12 IL IL14836800A patent/IL148368A0/xx active IP Right Grant
- 2000-09-12 CA CA002383222A patent/CA2383222C/en not_active Expired - Fee Related
- 2000-09-12 MX MXPA02002658A patent/MXPA02002658A/es active IP Right Grant
- 2000-09-12 HU HU0202671A patent/HUP0202671A3/hu unknown
- 2000-09-12 JP JP2001523001A patent/JP5116928B2/ja not_active Expired - Fee Related
- 2000-09-12 PL PL00353586A patent/PL353586A1/xx not_active Application Discontinuation
- 2000-09-12 US US10/069,663 patent/US7226934B1/en not_active Expired - Fee Related
- 2000-09-12 CN CN00815422A patent/CN1391475A/zh active Pending
- 2000-09-13 MY MYPI20004252A patent/MY134888A/en unknown
- 2000-09-13 AR ARP000104790A patent/AR034396A1/es not_active Application Discontinuation
2002
- 2002-02-25 IL IL148368A patent/IL148368A/en not_active IP Right Cessation
2007
- 2007-04-30 US US11/796,998 patent/US7557128B2/en not_active Expired - Fee Related
2009
- 2009-02-12 US US12/378,231 patent/US7872025B2/en not_active Expired - Fee Related
2011
- 2011-10-17 CY CY20111100984T patent/CY1112605T1/el unknown

Also Published As

Publication number	Publication date
PL353586A1 (en)	2003-12-01
IL148368A0 (en)	2002-09-12
US20080287498A1 (en)	2008-11-20
EP1218007A1 (en)	2002-07-03
JP2003509369A (ja)	2003-03-11
EP1218007A4 (en)	2003-04-09
IL148368A (en)	2007-10-31
EP1218007B1 (en)	2011-07-20
AU782816B2 (en)	2005-09-01
AR034396A1 (es)	2004-02-25
US7557128B2 (en)	2009-07-07
MXPA02002658A (es)	2002-10-23
BR0013935A (pt)	2002-05-14
US7872025B2 (en)	2011-01-18
CA2383222A1 (en)	2001-03-22
CA2383222C (en)	2008-11-18
JP5116928B2 (ja)	2013-01-09
PT1218007E (pt)	2011-10-27
HUP0202671A2 (hu)	2002-11-28
US7226934B1 (en)	2007-06-05
WO2001019367A1 (en)	2001-03-22
US20090149502A1 (en)	2009-06-11
CN1391475A (zh)	2003-01-15
ATE516804T1 (de)	2011-08-15
DK1218007T3 (da)	2011-11-07
CY1112605T1 (el)	2016-02-10
MY134888A (en)	2007-12-31
AU7701400A (en)	2001-04-17

Publication	Publication Date	Title
IL148368A0 (en)	2002-09-12	Optically active isomers of ketotifen and therapeutically active metabolites thereof
AU1936401A (en)	2001-06-12	Photodefinition of optical devices
AU2466099A (en)	1999-08-09	Pharmaceutically active compounds and methods of use thereof
ID22878A (id)	1999-12-16	Komposisi aktif secara terapi
AU7139898A (en)	1998-11-24	Active headset with bridge amplifier
AU3622600A (en)	2000-09-28	Metalloproteinases and methods of use therefor
DE50011566D1 (de)	2005-12-15	Elektrochrome gradientenblende
AU1410801A (en)	2001-05-30	Variants of alternative splicing
EP1179001A4 (en)	2002-08-21	METALLOPROTEINASE-5 (MT-MMP5-L) SPLICE VARIANT OF HUMAN MEMBRANE-TYPE MATRIX
IL130989A0 (en)	2001-01-28	Variants of alternative splicing
WO2001037113A8 (en)	2002-06-06	Permission-based marketing of events
AU5139800A (en)	2001-06-12	Topical administration of ketotifen
AU2001259422A1 (en)	2001-11-12	Immortalized lines of endothelial brain cells and therapeutic application thereof
TW415250U (en)	2000-12-11	New structure of goggles
TW488261U (en)	2002-05-21	Improved structure of embedded-type religious display
TW488260U (en)	2002-05-21	Structure of embedded-type religious display
TW388282U (en)	2000-04-21	Improved structure of goggles
IL132978A0 (en)	2001-03-19	Variants of alternative splicing
IL133455A0 (en)	2001-04-30	Variants of alternative splicing
TW501487U (en)	2002-09-01	Novel structure of goggles
DE60038936D1 (de)	2008-07-03	Einkristallziehvorrichtung
AUPQ050699A0 (en)	1999-06-17	Novel compounds and therapeutic methods-ii
TW302130U (en)	1997-04-01	Improved support structure of eye-protection goggle
TW437601U (en)	2001-05-28	Improvement of active ornament structure
SE9700660D0 (sv)	1997-02-25	Pharmaceutically active compounds